Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,333
Out of 4,944 analysts
55
Total ratings
68.09%
Success rate
24.48%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $128.78 | -6.82% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $77.37 | +68.02% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $67.77 | +62.31% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $5.48 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $79.44 | -60.66% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $14.63 | +139.23% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $121.24 | +143.32% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $52.64 | +72.89% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $53.92 | -49.93% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $311.59 | -78.50% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $128.78
Upside: -6.82%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $77.37
Upside: +68.02%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $67.77
Upside: +62.31%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $5.48
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $79.44
Upside: -60.66%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $14.63
Upside: +139.23%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $121.24
Upside: +143.32%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $52.64
Upside: +72.89%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $53.92
Upside: -49.93%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $311.59
Upside: -78.50%